Most scientists that have defended Avandia have financial ties to the drug's manufacturer

According to a paper published by a team of Mayo Clinic Researchers, most scientists who published articles supporting GlaxoSmithKline’s Avandia diabetes pill after it was linked to a risk of heart attacks in 2007 had financial ties to the drugmaker. Surprise, surprise! Go here for the story in Pharmalot. Go here for a copy of the paper. UPDATE (3/22): Here are links to other versions of this story in AboutLawsuits.com, Fierce Pharma and Bloomberg news